Contract awardedGenomic data platforms and bioinformatics

Genomic analysis software for NHS GGC comes from Congenica

NHS Greater Glasgow and Clyde extended its licence for a SaaS genomic analysis tool from Congenica Ltd, a small business.

Clinical scientists use the software to sort and interpret the genomic variants that next-generation sequencing turns up. That work feeds into how patients are diagnosed and treated.

NHS GGC awarded the six-month extension directly in September 2026, at £24,259. It keeps the clinical service running while a future procurement is prepared.

What
Genomic data platforms and bioinformatics
Value
£24,259
How it was bought
Award procedure without prior publication of a call for competition
1 bid
Dates and next
2 Sep 2026

How it was bought

1 official notice
  1. 24 Sep 2026Award noticePublic Contracts Scotland

NHS Greater Glasgow and Clyde has bought this twice since 2021

Last bought
Sep 2026
Typical value
£37,554
Suppliers used
2
AwardedContractWon byValue
Sep 2026LockedLocked£50,850
Sep 2026This purchaseCongenica Ltd£24,259

Suppliers NHS Greater Glasgow and Clyde has used

SupplierContractsValue
Locked1£50,850
Congenica Ltd Won this one1£24,259
See the contracts and who won them

Figures to 21 November 2026

How it compares

With every genomic data platforms and bioinformatics award since 2021

Half of awards fall between £50,425 and £402,778Median £166,278

Awards
72
Firms that won them
33
Median award
£166,278
of 71 with a value
This award
Smaller than 89%
of them
Typical length
1 year
In Scotland
5 awards

Congenica Ltd ranks 2nd of 33 firms for genomic data platforms and bioinformatics awards since 2021.

RankFirmAwardsValue
1Locked7£1.48m
2Congenica Ltd Won this one6£27.4m
3Locked5£2.88m
3Locked5£1.13m
5Locked4£21m
5Locked4£582,000
See who wins this work

Genomic data platforms and bioinformatics at other buyers

NHS Greater Glasgow and Clyde has awarded 422 contracts since 2021.

See NHS Greater Glasgow and Clyde's page
  • Congenica Ltd has won 7 public contracts since 2021.